ArticleInternational journal of urology : official journal of the Japanese Urological Association2026
Stone-Event-Free Survival After Ureteroscopic Lithotripsy According to Residual Fragment Size: Zero Residual Fragment Indicates a Good Prognosis.
Article in International journal of urology : official journal of the Japanese Urological Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aimed to evaluate how residual renal stone fragment size influences long-term stone-event-free survival after ureteroscopic lithotripsy (URSL), highlighting its clinical importance.
methodsWe retrospectively analyzed data from all patients who underwent URSL at our institution from 2008 to 2021. A total of 1334 cases were included and categorized into three groups based on their residual renal fragment size: 0 mm (1030 cases), < 4 mm (214 cases), and ≥ 4 mm (90 cases). Patient characteristics, surgical outcomes, and postoperative stone events were examined. Stone event-free survival rates were compared across these groups.
resultsDuring a mean follow-up of 763 days, 214 patients (16.0%) experienced stone events. The number of stone events in each group was 102 (9.9%) for 0 mm, 57 (26.6%) for < 4 mm, and 55 (61.1%) for ≥ 4 mm. The 1-year stone-event-free rates were 95.8%, 86.9%, and 44.9%, respectively, and the 5-year rates were 81.8%, 51.6%, and 28.0%. The reintervention-free rates at 1 year were 97.4%, 91.7%, and 50.5%, respectively, and at 5 years, they were 86.3%, 61.6%, and 35.5%. The log-rank test indicated significant differences in both stone-event-free and reintervention-free rates among the groups (p < 0.001). The multivariate Cox regression analysis revealed that the size of residual stones (0 mm versus < 4 mm and ≥ 4 mm) was the most significant factor in influencing stone events and re-interventions.
conclusionsThe size of residual fragments after URSL significantly influences long-term outcomes, emphasizing the importance of meticulous stone removal for optimal patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.